Treatment satisfaction and glycemic control in young Type 1 diabetic patients in transition from pediatric health care: CSII versus MDI
- 28 September 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Endocrine
- Vol. 46 (2), 256-262
- https://doi.org/10.1007/s12020-013-0060-6
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Standards of Medical Care in Diabetes—2013Diabetes Care, 2012
- Basal Supplementation of Insulin Lispro Protamine Suspension Versus Insulin Glargine and Detemir for Type 2 DiabetesDiabetes Care, 2012
- Glycemic Control in Youth with Diabetes: The SEARCH for Diabetes in Youth StudyThe Journal of Pediatrics, 2009
- In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargineDiabetic Medicine, 2008
- Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injectionsDiabetic Medicine, 2008
- Quality of life and metabolic control in patients with diabetes mellitus type 1 treated by continuous subcutaneous insulin infusion or multiple daily insulin injections.2004
- Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetesHealth Technology Assessment, 2004
- A Randomized, Prospective Trial Comparing the Efficacy of Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections Using Insulin GlargineDiabetes Care, 2004
- Poor Prognosis of Young Adults With Type 1 DiabetesDiabetes Care, 2003
- A Randomized Trial of Continuous Subcutaneous Insulin Infusion and Intensive Injection Therapy in Type 1 Diabetes for Patients With Long-Standing Poor Glycemic ControlDiabetes Care, 2002